drugset / Trial / NCT05830630
Perineural Methylene Blue Infusion in Lower Limb Amputation Surgery
RandomizedParallel-groupOpen-labelPrevention
Summary
This prospective randomized controlled study will be conducted to evaluate the analgesic effect of continuous perineural infusion of methylene blue with bupivacaine on acute postoperative pain and to evaluate its preventive role against chronic phantom pain in patients undergoing lower limb amputation surgery
Timeline
- Start
- 2023-05-01
- Primary completion
- 2027-02-01
- Completion
- 2027-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylene Blue | Diagnostic / imaging agent | 10 mg | Other |
| Background | Bupivacaine | Other / unclassified | 0.25 % | Other |
Indications
No indication recorded.